VIVUS is a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with serious unmet medical needs (obesity, sleep, and sexual health). It has developed two products: Qsymia and Stendra. Qsymia is the FDA-approved once-daily prescription weight-loss medicine that contains 2 ingredients that can help you lose weight and keep it off. Vivus has developed an erectile dysfunction drug, Avanafil, that has completed Phase 3 clinical trials. The drug has been approved for use by the FDA, and will be sold under the trademark name Stendra.